Humira (Hu-MARE-ah), a new biologic therapy for rheumatoid arthritis

Abbott is now introducing Humira (Hu-MARE-ah), a new biologic therapy for rheumatoid arthritis.

It's a tumor necrosis factor blocking agent...similar to Remicade (infliximab) and Enbrel (etanercept).

Humira is adalimumab...a human-derived antibody that binds to tumor necrosis factor (TNF).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote